Purchase Order HHSN271201700469P

The federal contract award HHSN271201500037A, valued at $498,000.00, was issued by the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services (HHS). The contract was awarded to Chemdiv, Inc., a for-profit organization based in San Diego, California, to provide small molecule compounds to support the National Center for Advancing Translational Sciences (NCATS) Pharmacologically Active Chemical Toolbox...

<p>This is a firm fixed-price purchase order awarded by the National Institute on Drug Abuse (NIDA), a civilian agency, to Edelris, a for-profit manufacturer, for the delivery of 5,050 proprietary chemical compounds at 1 milligram and 2 x 1 milligram each. The total ceiling value of the contract is $126,150.00, and the ultimate completion date is March 30, 2017. The contract does not have a set-aside designation.</p>

This is a $90,000.00 firm fixed price purchase order awarded by the National Institute on Drug Abuse (NIDA), which is a civilian agency of the U.S. government. The contract, which does not have a set-aside designation, is for the &quot;SMALL MOLECULES FOR NCATS PHARMACOLOGICALLY ACTIVE CHEMICAL TOOLBOX (NPACT)&quot; program and was awarded to DC Chemicals LIMITED, a for-profit limited liability company, on July 9, 2015. The period of performance for this contract ends on November 30, 2015.

The Department of Health and Human Services' National Institutes of Health National Institute on Drug Abuse awarded a $250,000.00 firm-fixed-price purchase order to the Baruch S. Blumberg Institute, a non-profit organization and foundation, for a project related to the &quot;NATURAL PRODUCTS EXTRACTS LIBRARY&quot; program. The award did not use a set-aside. The place of performance is Doylestown, Pennsylvania, and the award date was August 14, 2017, with a completion date of September 14, 2017.

The National Institute on Drug Abuse (NIDA), a civilian agency under the National Institutes of Health (NIH), awarded a $16,650.00 firm fixed-price purchase order contract to Novandi Chemistry AB, a manufacturer of goods based in Sweden. The contract is for the delivery of tritiated compounds to support binding experiments investigating novel receptor interactions in vivo. This contract award has no set-aside designation and is not associated with a larger contract vehicle. The contract work...

<p>The U.S. National Institute on Drug Abuse (NIDA), a civilian agency, awarded a $87,672.00 Firm Fixed Price Purchase Order contract to Glixx Laboratories, Inc., a self-certified small disadvantaged business. The contract is part of the Small Molecules for NCATS Pharmacologically Active Chemical Toolbox (NPACT) program, and has an ultimate completion date of November 30, 2015. The contract does not have a set-aside designation.</p>

This is a $249,500 firm fixed-price purchase order awarded by the Department of Health and Human Services' National Institutes of Health National Institute on Drug Abuse to Chemogenics Biopharma, LLC, a small business. The contract is for synthesis and bioanalytical analysis support services related to the therapeutic areas of the microbiome, neurodegeneration, and addiction. The services will augment existing medicinal chemistry campaigns within the National Center for Advancing Translational...

This is a $235,092.20 firm fixed-price purchase order awarded by the Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse to MedChemExpress LLC, a New Jersey-based provider of biochemicals and other life science research materials. The contract is for the delivery of a custom chemical library of 84 items to the National Center for Advancing Translational Sciences (NCATS) to support its COVID-19 research. No set-aside designation was used. As a...

Medchemexpress LLC was awarded a firm fixed price purchase order valued at seventy-seven thousand one hundred ninety-three dollars and forty-one cents ($77,193.41) by the Department of Health and Human Services' National Institutes of Health's National Institute on Drug Abuse to deliver one chemical library of five hundred nine bioactive compounds. The award originated from a sources sought notice issued by the National Institutes of Health's National Center for Advancing Translational...

<p>This is a $18,963.00 firm fixed price purchase order awarded by the National Institute on Drug Abuse (NIDA), a civilian agency, to NINDS PHARMAC LLC for medicinal chemistry consulting services. The contract has a Total Small Business set-aside designation. The contract was awarded on January 12, 2017 and has an ultimate completion date of January 12, 2022. The place of performance is Bethesda, Maryland.</p>